-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Mereo BioPharma Group plc quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from 2022 to Q1 2025.
- Mereo BioPharma Group plc Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2025 was -$320K, a 54.3% increase year-over-year.
- Mereo BioPharma Group plc annual Net Cash Provided by (Used in) Investing Activities for 2024 was -$699K, a 66.8% decline from 2023.
- Mereo BioPharma Group plc annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$419K, a 121% decline from 2022.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)